Citation Impact
Citing Papers
ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation
2009 StandoutScience
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Prognostic DNA Methylation Biomarkers in Ovarian Cancer
2006
H3K9 Histone Methyltransferase G9a Promotes Lung Cancer Invasion and Metastasis by Silencing the Cell Adhesion Molecule Ep-CAM
2010
Hierarchical Mechanisms for Direct Reprogramming of Fibroblasts to Neurons
2013 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma
2012
Circulating microRNAs as potential markers of human drug-induced liver injury
2011
Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis
2016
MYC on the Path to Cancer
2012 Standout
Epigenetic gene silencing in the Wnt pathway in breast cancer
2008
A view on drug resistance in cancer
2019 StandoutNature
The Role of Phenolic Compounds in the Fight against Cancer – A Review
2013
Chromatin Modifications and Their Function
2007 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Histone lysine demethylases as targets for anticancer therapy
2013
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
2013
Sex differences in histone modifications in the neonatal mouse brain
2009
Epigenetic regulation of normal and malignant hematopoiesis
2007
Nuclear receptor coregulators as a new paradigm for therapeutic targeting
2010
Integrating liquid biopsies into the management of cancer
2017
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer
2011
Histone methylation: a dynamic mark in health, disease and inheritance
2012 Standout
Hallmarks of aging: An expanding universe
2023 Standout
MicroRNA-150 Is a Potential Biomarker of HIV/AIDS Disease Progression and Therapy
2014
Multiparametric Analysis of Cell-Free DNA in Melanoma Patients
2012
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Histone demethylases in development and disease
2010
Cancer stem cells revisited
2017 Standout
Dynamic Regulation of Histone Lysine Methylation by Demethylases
2007
Prostate cancer and inflammation: the evidence
2011
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
2017
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
2016
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer
2014
High Fragmentation Characterizes Tumour-Derived Circulating DNA
2011
Gene methylation and early detection of genitourinary cancer: the road ahead
2007
The role of histone demethylases in cancer therapy
2012
Small-diameter hybrid vascular grafts composed of polycaprolactone and polydioxanone fibers
2017
Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?
2013
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
2012
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease
2008
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Emerging Biological Principles of Metastasis
2017 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
EMT: 2016
2016 Standout
LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis
2017
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Epigenetic modifications as therapeutic targets
2010
Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy
2008
KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family
2013
Cytoplasmic DNA: sources, sensing, and role in aging and disease
2021
Epigenetic modifications and human disease
2010 Standout
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
2010
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Cancer epigenomics: DNA methylomes and histone-modification maps
2007 Standout
Origins, structures, and functions of circulating DNA in oncology
2016
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
2012
Characterization of cell-free circulating DNA in plasma in patients with prostate cancer
2012
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
2010
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
2012
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
2010
Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
2009
Epigenetic Regulation of EMT: The Snail Story
2014
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Histone lysine demethylases: emerging roles in development, physiology and disease
2007
Histone lysine methylation and demethylation pathways in cancer
2010
LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer
2009
The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases
2011 StandoutNobel
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
Reversal of Histone Methylation: Biochemical and Molecular Mechanisms of Histone Demethylases
2010
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases
2015 StandoutNobel
BAP31 is frequently overexpressed in patients with primary colorectal cancer and correlates with better prognosis
2011
De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures
2017 StandoutNobel
Protein–Protein Interactions Mediated by Helical Tertiary Structure Motifs
2015
Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
2009
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Thyroid Hormone Regulation of Metabolism
2014 Standout
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
2009
Biology and targeting of the Jumonji-domain histone demethylase family in childhood neoplasia: a preclinical overview
2019
Mechanisms of Diabetic Complications
2013 Standout
Myc Enforces Overexpression ofEZH2in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
2011
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1α
2008 StandoutNobel
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Promoter Hypermethylation as an Independent Prognostic Factor for Relapse in Patients with Prostate Cancer Following Radical Prostatectomy
2005
Cell-free DNA level as a prognostic biomarker for epithelial ovarian cancer.
2012
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Works of Jörg Ellinger being referenced
The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer
2015
Identification of novel long non-coding RNAs in clear cell renal cell carcinoma
2015
MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels
2011
Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity
2008
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
2007
KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate-Specific Antigen-Relapse Following Radical Prostatectomy
2014
Pathological Outcomes of Men Eligible for Active Surveillance After Undergoing Radical Prostatectomy: Are Results Predictable?
2011
Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignancies
2010
H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1
2009
Global levels of histone modifications predict prostate cancer recurrence
2009
Soy isoflavone genistein in prevention and treatment of prostate cancer
2007
CpG Island hypermethylation in cell‐free serum DNA identifies patients with localized prostate cancer
2007
Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker
2009
Thulium Laser (Revolix) Vapoenucleation of the Prostate Is a Safe Procedure in Patients with an Increased Risk of Hemorrhage
2012
CpG Island Hypermethylation at Multiple Gene Sites in Diagnosis and Prognosis of Prostate Cancer
2008
Prognostic Value of CpG Island Hypermethylation at PTGS2, RAR-beta, EDNRB, and Other Gene Loci in Patients Undergoing Radical Prostatectomy
2006
Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy
2008
Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer
2011
Diagnostic and Prognostic Information in Prostate Cancer with the Help of a Small Set of Hypermethylated Gene Loci
2005
Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer.
2010
Androgen Receptor Coactivators Lysine-Specific Histone Demethylase 1 and Four and a Half LIM Domain Protein 2 Predict Risk of Prostate Cancer Recurrence
2006
CpG Island Hypermethylation of Cell-Free Circulating Serum DNA in Patients With Testicular Cancer
2009
Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer
2008
GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
2004
Prostaglandin content of tissue lining vascular prostheses.
1987